Navigation Links
Aesthera Announces Installation of 1000th Photopneumatic System in US
Date:6/4/2009

Over 1800 Systems Installed Worldwide in Under 4 years

PLEASANTON, Calif., June 4 /PRNewswire/ -- Aesthera today announced the installation of its 1000th Photopneumatic system in the United States. The installation of the 1000th system in the United States brings Aesthera's total installed base to approximately 1800 systems worldwide. The company has direct operations in the United States and Japan and a network of distributors in over 20 countries in Asia, Europe and the Middle East.

The 1000th Photopneumatic platform - the Isolaz Pro - was installed at the offices of Amy A. Vaughan, MD, of Amy A. Vaughan Dermatology, PLLC, a dermatologist in private practice in Barboursville, West Virginia. "Antibiotic resistance to acne is a growing concern for dermatologists and a rapidly growing number of physicians are moving away from using antibiotics as a primary weapon in the battle against acne. Even those physicians that do use antibiotics, often combine them with other treatment modalities that lessen drug resistance," says Dr. Vaughan. "Against this landscape, offering Isolaz treatments, especially to treat the more severe kinds of acne, was an obvious choice for our practice," she adds. Aesthera's Isolaz platform is the only FDA cleared device for the treatment of comedonal and pustular acne, in addition to a broad range of other indications, the company adds.

"The installation of our 1000th US system in less than 4 years post commercialization is a landmark achievement," says Alon Maor, Aesthera's President & CEO. During this period, the company commercialized its proprietary photopneumatic therapy, established the Isolaz as the premier treatment solution for acne and brought to market Profusion(TM) - a breakthrough skin therapy that combines Photopneumatic light treatments with the delivery of Aesthera's proprietary skincare to symbiotically enhance skin treatment outcomes for acne, body tightening, skin rejuvenation and skin lightening. "We are proud to be celebrating our 5th year in business and will continue to develop treatment solutions that strengthen our leadership position in the dermatology market," he adds.

About Photopneumatic(TM) Technology

Photopneumatic Therapy, that powers the Isolaz(TM) and Isolaz Pro(TM) system, is a proprietary combination of pneumatic energy and broad band light. Photopneumatic devices are the only laser or light based devices cleared for the treatment of inflammatory acne, comedonal acne and pustular acne. They are also cleared for the treatment of mild to moderate inflammatory acne. Additionally, Photopneumatic treatments have an immediate visible impact on acne 24 - 48 hour post first treatment and are painless. Facial treatments take approximately 10 minutes, require no anesthetics or numbing creams and provide additional cosmetic benefits such as smoother appearing skin. Additionally, Photopneumatic Therapy is also cleared for the treatment of benign vascular and pigmented lesions and hair removal.

About Aesthera Corporation

Aesthera (www.AESTHERA.com) develops, manufactures and markets light-based aesthetic treatment systems - the Isolaz(TM) and Isolaz Pro(TM) platforms - based on proprietary Photopneumatic(TM) technology.

About Amy A. Vaughan, MD

Dr. Amy A. Vaughan, MD is a board certified dermatologist. Her private practice, Amy A. Vaughan Dermatology, PLLC is located in Barboursville, WV. To contact Dr. Vaughan or schedule an appointment, please call 304.733.3333

    Contact:
    Sarvar Kothavala
    Aesthera Corp.
    415.760.0902
    SKothavala@Aesthera.com


'/>"/>
SOURCE Aesthera
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek ... services to families and business owners across eastern Michigan, is connecting with the ... struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ensure ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June 9, ... Benefit Claims Litigation seminar in Chicago, Illinois. She will present on: , ... cases litigated under ERISA involve claims for long-term disability benefits. This session ...
(Date:3/24/2017)... ... March 24, 2017 , ... Judy ... Reiki™ Master in Frederick, MD. Judy says, “I am passionate about sharing Reiki ... often a very difficult and challenging time.” , A Certified Medical Reiki™ Master ...
(Date:3/24/2017)... ... 24, 2017 , ... “The Adventures of Joey, The Dog Who Barks at ... his life to the fullest, as God intended. “The Adventures of Joey, The Dog ... and grandmother pursuing her passion for writing, especially about truth and human behavior. , ...
(Date:3/23/2017)... ... 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased to ... 2. The clinic is the group’s second in New Braunfels and 22nd in Texas. ... New Braunfels location brings things full circle for the group, “It’s crazy to think ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... and Diagnostics, 2017 - 2035" report to their offering. ... The Deep Learning: Drug ... future outlook of the growing market of deep learning solutions within ... learning algorithms have emerged as a novel solution to generate relevant ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, a ... medical technology for non-invasive surgery, announced today CE ... for treatment of uterine fibroids throughout the European ... received approval from the US Food and Drug ... Mirabilis System in the United States.  The Mirabilis ...
Breaking Medicine Technology: